Infarct quantification using 3D inversion recovery and 2D phase sensitive inversion recovery; validation in patients and ex vivo.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968539 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2261 (Electronic) Linking ISSN: 14712261 NLM ISO Abbreviation: BMC Cardiovasc Disord Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Contrast Media*; Imaging, Three-Dimensional/*methods ; Magnetic Resonance Imaging, Cine/*methods ; Myocardial Infarction/*diagnosis ; Myocardial Infarction/*physiopathology; Adult ; Aged ; Animals ; Female ; Gadolinium ; Humans ; Male ; Middle Aged ; Swine
    • Abstract:
      Background: Cardiovascular-MR (CMR) is the gold standard for quantifying myocardial infarction using late gadolinium enhancement (LGE) technique. Both 2D- and 3D-LGE-sequences are used in clinical practise and in clinical and experimental studies for infarct quantification. Therefore the aim of this study was to investigate if image acquisitions with 2D- and 3D-LGE show the same infarct size in patients and ex vivo.
      Methods: Twenty-six patients with previous myocardial infarction who underwent a CMR scan were included. Images were acquired 10-20 minutes after an injection of 0.2 mmol/kg gadolinium-based contrast agent. Two LGE-sequences, 3D-inversion recovery (IR) and 2D-phase-sensitive (PS) IR, were used in all patients to quantify infarction size. Furthermore, six pigs with reperfused infarction in the left anterior descending artery (40 minutes occlusion and 4 hours of reperfusion) were scanned with 2D- and 3D-LGE ex vivo. A high resolution T1-sequence was used as reference for the infarct quantification ex vivo. Spearman's rank-order correlation, Wilcoxon matched pairs test and bias according to Bland-Altman was used for comparison of infarct size with different LGE-sequences.
      Results: There was no significant difference between the 2D- and 3D-LGE sequence in left ventricular mass (LVM) (2D: 115 ± 25 g; 3D: 117 ± 24 g: p = 0.35). Infarct size in vivo using 2D- and 3D-LGE showed high correlation and low bias for both LGE-sequences both in absolute volume of infarct (r = 0.97, bias 0.47 ± 2.1 ml) and infarct size as part of LVM (r = 0.94, bias 0.16 ± 2.0%). The 2D- and 3D-LGE-sequences ex vivo correlated well (r = 0.93, bias 0.67 ± 2.4%) for infarct size as part of the LVM. The IR LGE-sequences overestimated infarct size as part of the LVM ex vivo compared to the high resolution T1-sequence (bias 6.7 ± 3.0%, 7.3 ± 2.7% for 2D-PSIR and 3D-IR respectively, p < 0.05 for both).
      Conclusions: Infarct quantification with 2D- and 3D-LGE gives similar results in vivo with a very low bias. IR LGE-sequences optimized for in vivo use yield an overestimation of infarct size when used ex vivo.
    • References:
      Am Heart J. 2005 Nov;150(5):920. (PMID: 16290962)
      Lancet. 2003 Feb 1;361(9355):374-9. (PMID: 12573373)
      J Magn Reson Imaging. 2004 Sep;20(3):378-82. (PMID: 15332243)
      N Engl J Med. 2000 Nov 16;343(20):1445-53. (PMID: 11078769)
      Circulation. 2004 Sep 21;110(12):1535-41. (PMID: 15353496)
      Radiology. 2004 Mar;230(3):845-51. (PMID: 14990846)
      Radiology. 2008 Feb;246(2):581-8. (PMID: 18055873)
      Radiology. 2001 Jan;218(1):215-23. (PMID: 11152805)
      Radiology. 2004 Jul;232(1):49-57. (PMID: 15166320)
      Acad Radiol. 2007 Jul;14(7):788-94. (PMID: 17574129)
      J Cardiovasc Magn Reson. 2009 Sep 23;11:38. (PMID: 19775428)
      Magn Reson Med. 2002 Feb;47(2):372-83. (PMID: 11810682)
      Radiology. 2004 Feb;230(2):576-82. (PMID: 14688401)
      J Cardiovasc Magn Reson. 2003 Jul;5(3):505-14. (PMID: 12882082)
      BMC Cardiovasc Disord. 2010 Sep 27;10:45. (PMID: 20875134)
      BMC Med Imaging. 2010 Jan 11;10:1. (PMID: 20064248)
      Circulation. 1999 Nov 9;100(19):1992-2002. (PMID: 10556226)
      Radiology. 2011 Jun;259(3):704-11. (PMID: 21467254)
      AJR Am J Roentgenol. 2009 Nov;193(5):W381-8. (PMID: 19843715)
      BMC Cardiovasc Disord. 2008 Apr 10;8:7. (PMID: 18402663)
      J Cardiovasc Magn Reson. 2010 Apr 30;12:25. (PMID: 20433716)
      JACC Cardiovasc Imaging. 2009 May;2(5):569-76. (PMID: 19442942)
      J Magn Reson Imaging. 2008 Apr;27(4):802-8. (PMID: 18302233)
      Eur Heart J. 2012 May;33(10):1268-78. (PMID: 22279111)
      J Electrocardiol. 2008 Nov-Dec;41(6):614-20. (PMID: 18817927)
      Scand Cardiovasc J. 2005 Oct;39(5):267-75. (PMID: 16269396)
      Radiology. 2006 Jun;239(3):703-9. (PMID: 16641341)
      BMC Med Imaging. 2010 Jan 24;10:4. (PMID: 20096134)
    • Accession Number:
      0 (Contrast Media)
      AU0V1LM3JT (Gadolinium)
    • Publication Date:
      Date Created: 20131207 Date Completed: 20140422 Latest Revision: 20220309
    • Publication Date:
      20240628
    • Accession Number:
      PMC4029523
    • Accession Number:
      10.1186/1471-2261-13-110
    • Accession Number:
      24308673